Parnassus Investments
Parnassus Endeavor Fund
Parnassus Endeavor Fund UnitedHealth Group Incorporated stake
total: 118
Parnassus Endeavor Fund UNH trades
- Total transactions:
- 8
- New positions:
- 1
- Added:
- 3
- Reduced:
- 4
- Held since:
- 2024 Q3
- Held for:
- 8 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Parnassus Endeavor Fund holds 194,120 UnitedHealth Group Incorporated (UNH) shares with a market value of roughly $80.68M accounting for 1.53% of the overall portfolio. To date, the estimated cost basis is nearly $573.83 for "buy" trades and estimated average "sell" price is $334.88. Parnassus Endeavor Fund first purchased UNH in 2024 Q3, initially acquiring 188,370 shares. Since the initial investment in UnitedHealth Group Incorporated (UNH), Parnassus Endeavor Fund has made 7 more transactions.
When did Parnassus Endeavor Fund buy UnitedHealth Group Incorporated (UNH)?
Parnassus Endeavor Fund first invested in UnitedHealth Group Incorporated (UNH) in 2024 Q3 at the reported quarter-end price of $584.68 per share.
What's the cost basis of Parnassus Endeavor Fund's UNH stake?
The estimated cost basis for UnitedHealth Group Incorporated (UNH) stake is around $573.83 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $573.83
- Weighted AVG sell price:
- $334.88
Parnassus Endeavor Fund's historical trades in UnitedHealth Group Incorporated
8 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
1.53%
|
194,120
|
$415.63
|
$80,682,096
|
-2.21% (-4,381)
|
-0.04%
|
|
2026 Q1
|
1.16%
|
198,501
|
$270.59
|
$53,712,386
|
-0.21% (-423)
|
-0%
|
|
2025 Q4
|
1.38%
|
198,924
|
$330.11
|
$65,666,802
|
-4.42% (-9,209)
|
-0.06%
|
|
2025 Q3
|
1.53%
|
208,133
|
$345.30
|
$71,868,325
|
+0.08% (+173)
|
+0%
|
|
2025 Q2
|
1.43%
|
207,960
|
$311.97
|
$64,877,281
|
-5.60% (-12,336)
|
-0.09%
|
|
2025 Q1
|
2.58%
|
220,296
|
$523.75
|
$115,380,030
|
+4.37% (+9,217)
|
+0.11%
|
|
2024 Q4
|
2.22%
|
211,079
|
$505.86
|
$106,776,423
|
+12.06% (+22,709)
|
+0.24%
|
|
2024 Q3
|
2.18%
|
188,370
|
$584.68
|
$110,136,172
|
new
|
+2.18%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.